Hau Bosun

Director at Cellular Biomedicine Group, Inc. · on record since Mar 13, 2018
Director at Evolus, Inc. · on record since Feb 7, 2018
Director at BICYCLE THERAPEUTICS PLC · on record since May 23, 2019
Director at EXICURE, INC. · on record since Aug 6, 2019

Insider trading activity of Hau Bosun

Transactions on record: 10; since Mar 13, 2018

Open-market buys: 2; $309.7K

Open-market sells: 0

Companies traded: 3; last filing Jun 4, 2021

Figures computed from official regulatory filings — .

Companies where Hau Bosun has traded

EXICURE, INC.3 tx · Jun 4, 2021
Evolus, Inc.5 tx · $309.7K · Jan 24, 2020
Cellular Biomedicine Group, Inc.2 tx · May 22, 2018

Track record of Hau Bosun

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hau Bosun

Co-insiders of Hau Bosun

NOVARTIS AGBICYCLE THERAPEUTICS PLC +1
667, L.P.BICYCLE THERAPEUTICS PLC
Ahn ChangilEXICURE, INC.
Alphaeon 1 LLCEvolus, Inc.
Alphaeon CorpEvolus, Inc.
Anstey MichaelBICYCLE THERAPEUTICS PLC
AQUILA INVESTMENTS IVBICYCLE THERAPEUTICS PLC
Arroyo SantiagoBICYCLE THERAPEUTICS PLC
Au Chun Kwok AlanCellular Biomedicine Group, Inc.
Auerbach Jeffrey H.Cellular Biomedicine Group, Inc.
AURASENSE LLCEXICURE, INC.
Avelar RuiEvolus, Inc.
Baik Seung IkEXICURE, INC.
Baker Bros. Advisors (GP) LLCBICYCLE THERAPEUTICS PLC
BAKER BROS. ADVISORS LPBICYCLE THERAPEUTICS PLC
Baker Brothers Life Sciences LPBICYCLE THERAPEUTICS PLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
EXICURE, INC.Listing on record	Jun 4, 2021	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXICURE, INC.Listing on record	Jun 8, 2020	AwardD (derivative)	21,693	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evolus, Inc.Listing on record	Jan 24, 2020	AwardD (derivative)	23,458	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXICURE, INC.Listing on record	Aug 6, 2019	AwardD (derivative)	43,386	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evolus, Inc.Listing on record	Jan 25, 2019	AwardD (derivative)	14,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evolus, Inc.Listing on record	Jun 8, 2018	Buy	2,898	34.94 USD	$101.3K	conv 32	SEC
Evolus, Inc.Listing on record	Jun 5, 2018	Buy	7,142	29.19 USD	$208.5K	conv 37First in 12mo	SEC
Cellular Biomedicine Group, Inc.Listing unverified	May 22, 2018	AwardD (derivative)	4,499	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evolus, Inc.Listing on record	Apr 26, 2018	AwardD (derivative)	9,086	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellular Biomedicine Group, Inc.Listing unverified	Mar 13, 2018	AwardD (derivative)	285	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
EXICURE, INC.Listing on record	Jun 4, 2021	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXICURE, INC.Listing on record	Jun 8, 2020	AwardD (derivative)	21,693	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evolus, Inc.Listing on record	Jan 24, 2020	AwardD (derivative)	23,458	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXICURE, INC.Listing on record	Aug 6, 2019	AwardD (derivative)	43,386	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evolus, Inc.Listing on record	Jan 25, 2019	AwardD (derivative)	14,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evolus, Inc.Listing on record	Jun 8, 2018	Buy	2,898	34.94 USD	$101.3K	conv 32	SEC
Evolus, Inc.Listing on record	Jun 5, 2018	Buy	7,142	29.19 USD	$208.5K	conv 37First in 12mo	SEC
Cellular Biomedicine Group, Inc.Listing unverified	May 22, 2018	AwardD (derivative)	4,499	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evolus, Inc.Listing on record	Apr 26, 2018	AwardD (derivative)	9,086	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellular Biomedicine Group, Inc.Listing unverified	Mar 13, 2018	AwardD (derivative)	285	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC